SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer
SAMHD1 表达是免疫浸润的替代标志物，可决定早期乳腺癌新辅助化疗后的预后
期刊:Cellular Oncology
影响因子:
doi:10.1007/s13402-023-00862-1
Lucía Gutiérrez-Chamorro #, Eudald Felip #, Eva Castellà, Vanessa Quiroga, Ifeanyi Jude Ezeonwumelu, Laura Angelats, Anna Esteve, Laia Perez-Roca, Anna Martínez-Cardús, Pedro Luis Fernandez, Angelica Ferrando-Díez, Anna Pous, Milana Bergamino, Beatriz Cirauqui, Marga Romeo, Iris Teruel, Ricard Mesia
